This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Clinical trial NCT06862206 · RECRUITING

Trial details

NCT number: NCT06862206
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2025-07-11
Primary completion: 2028-01-30
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.